Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue - PubMed (original) (raw)
Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue
H Kitamura et al. Histopathology. 2006 Jan.
Abstract
Aims: To investigate the expression of p62 in various prostatic tissues, and to demonstrate different immunohistochemical patterns of p62 expression in distinct pathological entities of the prostate. The p62 sequestosome 1 (SQSTM1) gene product is a multifunctional protein with ubiquitous expression in normal adult tissue.
Methods and results: Overexpression of p62 was detected in prostate cancer cell lines and tissues by reverse transcriptase-polymerase chain reaction. Immunohistochemical staining for p62 was performed on 73 cases of paraffin-embedded prostatic tissue. p62 was negative or weakly positive only in the nucleus (pattern N) of prostatic gland epithelium in nine normal and hyperplastic prostate specimens, whilst most cancerous tissue showed intense, uniform staining for p62 in the cytoplasm (pattern C). Of the prostate cancer specimens, 91% showed positive pattern C immunoreactivity. Of the cases with high-grade prostatic intraepithelial neoplasia (PIN) around cancer, 77% showed pattern C. However, in specimens from the patients without prostate cancer PIN displayed pattern C in only 32% of cases. Western blot analysis showed that all cancer cell lines expressed p62 in the cytoplasm but there was little nuclear expression.
Conclusion: Cytosolic overexpression of p62 is a novel immunohistochemical characteristic in prostatic adenocarcinoma and high-grade PIN, suggesting that p62 might be a novel marker for prostatic malignancy.
Similar articles
- Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
Bostwick DG, Qian J, Maihle NJ. Bostwick DG, et al. Prostate. 2004 Feb 1;58(2):164-8. doi: 10.1002/pros.10322. Prostate. 2004. PMID: 14716741 - Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
Bethel CR, Faith D, Li X, Guan B, Hicks JL, Lan F, Jenkins RB, Bieberich CJ, De Marzo AM. Bethel CR, et al. Cancer Res. 2006 Nov 15;66(22):10683-90. doi: 10.1158/0008-5472.CAN-06-0963. Cancer Res. 2006. PMID: 17108105 - Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia.
Zhou T, Xu C, He M, Sun Y. Zhou T, et al. Prostate Cancer Prostatic Dis. 2008;11(2):143-7. doi: 10.1038/sj.pcan.4500995. Epub 2007 Jul 17. Prostate Cancer Prostatic Dis. 2008. PMID: 17637760 - [High-grade prostatic intraepithelial neoplasia: state-of-the-art].
Allina DO, Andreeva YY, Zavalishina LE, Kekeeva TV, Frank GA. Allina DO, et al. Arkh Patol. 2015 Jan-Feb;77(1):69-74. doi: 10.17116/patol201577169-. Arkh Patol. 2015. PMID: 25868372 Review. Russian. - Epidemiology and molecular biology of early prostatic neoplasia.
Sakr WA, Ward C, Grignon DJ, Haas GP. Sakr WA, et al. Mol Urol. 2000 Fall;4(3):109-13;discussion 115. Mol Urol. 2000. PMID: 11062364 Review.
Cited by
- Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy.
Xing Z, Jiang X, Wu Y, Yu Z. Xing Z, et al. Curr Cancer Drug Targets. 2024;24(9):890-909. doi: 10.2174/0115680096273730231206054104. Curr Cancer Drug Targets. 2024. PMID: 38275055 Review. - p62 Is a Potential Biomarker for Risk of Malignant Transformation of Oral Potentially Malignant Disorders (OPMDs).
Takasaki R, Uchida F, Takaoka S, Ishii R, Fukuzawa S, Warabi E, Ishibashi-Kanno N, Yamagata K, Bukawa H, Yanagawa T. Takasaki R, et al. Curr Issues Mol Biol. 2023 Sep 19;45(9):7630-7641. doi: 10.3390/cimb45090480. Curr Issues Mol Biol. 2023. PMID: 37754264 Free PMC article. - Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex.
Moscat J, Diaz-Meco MT, Wooten MW. Moscat J, et al. Cell Death Differ. 2009 Nov;16(11):1426-37. doi: 10.1038/cdd.2009.119. Epub 2009 Aug 28. Cell Death Differ. 2009. PMID: 19713972 Free PMC article. Review. - Immunohistochemical Expression of p62 in Feline Mammary Carcinoma and Non-Neoplastic Mammary Tissue.
Magi GE, Mariotti F, Pallotta L, Di Cerbo A, Venanzi FM. Magi GE, et al. Animals (Basel). 2022 Aug 2;12(15):1964. doi: 10.3390/ani12151964. Animals (Basel). 2022. PMID: 35953953 Free PMC article. - Immunohistochemical assessment of autophagic protein LC3B and p62 levels in glioma patients.
Jiang T, Wu Z. Jiang T, et al. Int J Clin Exp Pathol. 2018 Feb 1;11(2):862-868. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938176 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical